Occudo Quantitative Strategies LP Kinnate Biopharma Inc. Transaction History

Occudo Quantitative Strategies LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.24 - $2.66 $109,509 - $130,042	-48,888 Reduced 70.03%	20,925 $55,000
Q4 2023 Feb 14, 2024	BUY	$1.07 - $2.5 $74,699 - $174,532	69,813 New	69,813 $165,000
Q2 2023 Aug 14, 2023	BUY	$2.33 - $6.84 $35,963 - $105,575	15,435 New	15,435 $46,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.